Quick answers
- What is Pentam 300?
- Pentam 300 is a brand name of Pentamidine, a prescription medicine. The FDA NDC Directory lists 1 Pentam 300 product in 1 strength and form.
- Who makes Pentam 300?
- Fresenius Kabi USA holds the FDA application for Pentam 300 (NDA019264, approved October 16, 1984).
- Is there a generic or store brand of Pentam 300?
- Other products of Pentamidine are listed with the FDA, but none in exactly the same strength and form as a Pentam 300 product.
- Has Pentam 300 been recalled?
- No recall linked to Pentam 300 products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Pentam 300 is
Each Pentam 300 product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Pentamidine · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| pentamidine isethionate 300 mg/3 mL injection, powder, lyophilized, for solution (intramuscular, intravenous) | Pentam 300 | None listed | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Pentamidine →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA019264 | Fresenius Kabi USA | October 16, 1984 | 1 |
Companies that list Pentam 300
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Pentam 300 products.
- Fresenius Kabi USA, LLC1 product
Recalls
No recall linked to Pentam 300 products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.